Jingchuan Zhang
AstraZeneca R&D
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Oncogenic HER2 fusions in gastric cancer.
Journal: Journal of translational medicine
Published: December 29, 2014
Establishment and characterization of esophageal squamous cell carcinoma patient-derived xenograft mouse models for preclinical drug discovery.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: February 15, 2014
The AKT inhibitor AZD5363 is selectively active in PI3KCA mutant gastric cancer, and sensitizes a patient-derived gastric cancer xenograft model with PTEN loss to Taxotere.
Journal: Journal of translational medicine
Published: July 11, 2013
FGFR2 gene amplification in gastric cancer predicts sensitivity to the selective FGFR inhibitor AZD4547.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 16, 2013
Establishment of patient-derived non-small cell lung cancer xenograft models with genetic aberrations within EGFR, KRAS and FGFR1: useful tools for preclinical studies of targeted therapies.
Journal: Journal of translational medicine
Published: March 12, 2013
Translating the therapeutic potential of AZD4547 in FGFR1-amplified non-small cell lung cancer through the use of patient-derived tumor xenograft models.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 20, 2012
Trastuzumab anti-tumor efficacy in patient-derived esophageal squamous cell carcinoma xenograft (PDECX) mouse models.
Journal: Journal of translational medicine
Published: May 03, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026